Administrative doctors could face liability for issuing a prescription against the rules. The bill provides for such punishment, published for public access and discussion of the Ministry of Health.
Office document posted on a single portal of information disclosure. It says that for doctors prescription for failure to comply with the requirements of international non-proprietary name (INN), - will be punished by a fine. In other words, will be fined doctors pointing to a specific brand name prescription drug, and is not international nonproprietary name.
For reference
The procedure for prescribing drugs by the international non-proprietary name (and if its absence - a grouping name) was approved by the Russian Ministry of Health with July 1, 2013. In accordance with the doctors when prescribing should specify only the active ingredient (for example, "No-spa" and drotaverine).
For non-observance of these rules Office threatened with fines, but from 1 January 2014, as planned Ministry of Health earlier, the fines have not been formally introduced.
Now a bill on administrative Responsibility for the medical prescription of the wrong design takes place public discussion. If approved, it will take effect from 1 January 2015 year. (READ MORE)
Office document posted on a single portal of information disclosure. It says that for doctors prescription for failure to comply with the requirements of international non-proprietary name (INN), - will be punished by a fine. In other words, will be fined doctors pointing to a specific brand name prescription drug, and is not international nonproprietary name.
"Violation of the health worker established procedure for the appointment and prescribing medicines for medical use entails warning or imposition of an administrative a fine of between two and three thousand rubles, "- said in the document.
For reference
The procedure for prescribing drugs by the international non-proprietary name (and if its absence - a grouping name) was approved by the Russian Ministry of Health with July 1, 2013. In accordance with the doctors when prescribing should specify only the active ingredient (for example, "No-spa" and drotaverine).
For non-observance of these rules Office threatened with fines, but from 1 January 2014, as planned Ministry of Health earlier, the fines have not been formally introduced.
Now a bill on administrative Responsibility for the medical prescription of the wrong design takes place public discussion. If approved, it will take effect from 1 January 2015 year. (READ MORE)
Industry News
Go back to the main page
No comments:
Post a Comment